PURPOSE: The aim of the present study is to evaluate the formulation effect on the oral absorption of poorly water-soluble drugs using a dissolution/permeation system (D/P system). METHODS: This D/P system, consisting of apical and basal chambers and a Caco-2 cell monolayer mounted between chambers, can be used to perform simultaneous analysis of drug dissolution and permeation process of drugs applied as various dosage forms. Oral administration study with rats was also performed for both drugs as the same dosage forms. RESULTS: When danazol, a low-soluble and high-permeable drug, was applied to the D/P system as various formulations, dissolved and permeated amounts were significantly high compared with those from a suspension form. On the other hand, whereas the dissolved amount of pranlukast, a low-soluble and low-permeable drug, was significantly increased by formulations, there were no significant changes observed in the permeated amount between suspension and formulation. The oral availability of danazol was significantly increased by formulations but not pranlukast, which corresponded well to in vitro evaluations. CONCLUSION: These results indicated that the D/P system might be applicable for selection of formulation on the basis of physicochemical drug properties.
PURPOSE: The aim of the present study is to evaluate the formulation effect on the oral absorption of poorly water-soluble drugs using a dissolution/permeation system (D/P system). METHODS: This D/P system, consisting of apical and basal chambers and a Caco-2 cell monolayer mounted between chambers, can be used to perform simultaneous analysis of drug dissolution and permeation process of drugs applied as various dosage forms. Oral administration study with rats was also performed for both drugs as the same dosage forms. RESULTS: When danazol, a low-soluble and high-permeable drug, was applied to the D/P system as various formulations, dissolved and permeated amounts were significantly high compared with those from a suspension form. On the other hand, whereas the dissolved amount of pranlukast, a low-soluble and low-permeable drug, was significantly increased by formulations, there were no significant changes observed in the permeated amount between suspension and formulation. The oral availability of danazol was significantly increased by formulations but not pranlukast, which corresponded well to in vitro evaluations. CONCLUSION: These results indicated that the D/P system might be applicable for selection of formulation on the basis of physicochemical drug properties.
Authors: Jonathan M Miller; Avital Beig; Brian J Krieg; Robert A Carr; Thomas B Borchardt; Gregory E Amidon; Gordon L Amidon; Arik Dahan Journal: Mol Pharm Date: 2011-08-11 Impact factor: 4.939
Authors: Andy Z X Zhu; Ming-Chih David Ho; Christopher K Gemski; Bei-Ching Chuang; Mingxiang Liao; Cindy Q Xia Journal: AAPS J Date: 2016-09-06 Impact factor: 4.009
Authors: Hywel D Williams; Natalie L Trevaskis; Yan Yan Yeap; Mette U Anby; Colin W Pouton; Christopher J H Porter Journal: Pharm Res Date: 2013-07-04 Impact factor: 4.200